HK inno.N
Farmaceutische formuleringen, generieke medicijnen en gezondheidszorgproducten.
HK inno.N produceert farmaceutische formuleringen, generieke medicijnen en gezondheidszorgproducten vanuit haar activiteiten in Seoul. Het bedrijf levert aan apotheekkanalen, ziekenhuisinkopers, distributeurs in de gezondheidszorg of exportklanten op zijn beursgenoteerde primaire markten.
- Type
- Manufacturer
- Location
- Seoul, South Korea
- Founded
- 1984
- Website
- hkinno-n.com
- Categories
- Medische en gezondheidszorgbenodigdheden, Supplementen & Welzijn
- Markets
- Zuid-Korea, China, Verenigde Staten, Japan
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)